✦ LIBER ✦

NYGGF4 as a new therapeutic target for obesity-associated insulin resistance

✍ Scribed by Zhangbin Yu; Xirong Guo

Book ID: 116746331
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 133 KB
Volume: 78
Category: Article
ISSN: 0306-9877
DOI: 10.1016/j.mehy.2012.01.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The incretin pathway as a new therapeuti

The incretin pathway as a new therapeutic target for obesity

✍ Thomas M. Barber; Helen Begbie; Jonathan Levy 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 268 KB

Targeting protein kinase C epsilon or th

Targeting protein kinase C epsilon or theta as a therapeutic strategy for insulin resistance

✍ Carsten Schmitz-Peiffer 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 145 KB

The histamine H4 receptor as a new thera

The histamine H4 receptor as a new therapeutic target for inflammation

✍ Iwan J.P. de Esch; Robin L. Thurmond; Aldo Jongejan; Rob Leurs 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 333 KB

Obesity/insulin resistance is associated

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.

✍ Steinberg, H O; Chaker, H; Leaming, R; Johnson, A; Brechtel, G; Baron, A D 📂 Article 📅 1996 🏛 American Society for Clinical Investigation 🌐 English ⚖ 200 KB

Adipose tissue angiogenesis as a therape

Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases

✍ Cao, Yihai 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 827 KB

Adiponectin as a therapeutic target for

Adiponectin as a therapeutic target for obesity-related metabolic and cardiovascular disorders

✍ Yu Wang; Karen S.L. Lam; Aimin Xu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB